Cargando…
Synthesis of 2,4-Diaminopyrimidine Core-Based Derivatives and Biological Evaluation of Their Anti-Tubercular Activities
Tuberculosis (TB) is a chronic, potentially fatal disease caused by Mycobacterium tuberculosis (Mtb). The dihyrofolate reductase in Mtb (mt-DHFR) is believed to be an important drug target in anti-TB drug development. This enzyme contains a glycerol (GOL) binding site, which is assumed to be a usefu...
Autores principales: | Ouyang, Yifan, Yang, Hao, Zhang, Peng, Wang, Yu, Kaur, Sargit, Zhu, Xuanli, Wang, Zhe, Sun, Yutong, Hong, Wei, Ngeow, Yun Fong, Wang, Hao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151568/ https://www.ncbi.nlm.nih.gov/pubmed/28937657 http://dx.doi.org/10.3390/molecules22101592 |
Ejemplares similares
-
Synthesis and Biological Evaluation of 2,4-Diaminopyrimidine-Based Antifolate Drugs against Bacillus anthracis
por: Nammalwar, Baskar, et al.
Publicado: (2014) -
Differences in Coformer Interactions of the 2,4-Diaminopyrimidines
Pyrimethamine and Trimethoprim
por: Alaa Eldin Refat, Lamis, et al.
Publicado: (2022) -
A novel bicyclic 2,4-diaminopyrimidine inhibitor of Streptococcus suis dihydrofolate reductase
por: Songsungthong, Warangkhana, et al.
Publicado: (2021) -
Design of Anticancer 2,4-Diaminopyrimidines as Novel Anoctamin 1 (ANO1) Ion Channel Blockers
por: Kim, Taewoo, et al.
Publicado: (2020) -
2,4-Diaminopyrimidines as Potent Inhibitors of Trypanosoma brucei and Identification of Molecular Targets by a Chemical Proteomics Approach
por: Mercer, Luke, et al.
Publicado: (2011)